Data-Driven Assessment of Lung Cancer Patients Using Performance Status and Wearable Device Metrics
Studies in Health Technology and Informatics · 2025
DOI: 10.3233/shti250074 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift Studies in Health Technology and Informatics, 2025. Verfasst von Ioannis Bilionis und 5 weiteren Autor:innen. Beteiligte Einrichtung: Adhera Health Inc., Santa Cruz, CA, USA. Hauptthemen laut MEDLINE: Lung Neoplasms, Wearable Electronic Devices, Mobile Applications. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Themen: Onkologische Pflege
Abstract (Originalsprache)
Lung cancer remains a leading cause of cancer-related deaths globally, with non-small cell lung cancer (NSCLC) accounting for 85% of cases. Traditional methods for assessing the clinical status of cancer patients, such as Performance Status (PS), are subjective and may lack consistency across clinicians. Lung cancer remains a leading cause of cancer-related mortality worldwide. Monitoring the physical activity and PS of patients undergoing treatment is crucial for tailored therapeutic interventions. The LUPA study is a non-interventional, two-phase observational study aimed at assessing the usability of wearable devices and a mobile application for monitoring activity, sleep quality, and symptoms in lung cancer patients. A mixed-methods approach was used in Phase I to assess usability and data utility, while Phase II involved a one-group observational clinical study with 61 patients to explore correlations between clinician-reported PS and data collected through wearables. The results suggest moderate correlations between wearable data and ECOG-PS scores, but challenges remain in applying machine learning (ML) models to predict changes in patient condition. Future work should address model refinement, increased sample size, and the incorporation of additional features from wearable devices to enhance predictive accuracy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Adhera Health Inc., Santa Cruz, CA, USA.
- Hospital Universitario 12 de Octubre, Madrid, Spain.
- Medical Oncology Department, Catalan Institute of Oncology, Dr. Josep Trueta University Hospital and OncoGIR-PRO (Precision Oncology Group), Girona Biomedical Research Institute (IDIBGI-CERCA), Girona, Catalonia, Spain.
- Roche Farma SA, Madrid, Spain.
Zitieren
APA
Bilionis, I., Fernandez Luque, L., Ponce Aix, S., Bosch-Barrera, J., Arnaiz, P., & Flores, A. (2025). Data-Driven Assessment of Lung Cancer Patients Using Performance Status and Wearable Device Metrics. Studies in Health Technology and Informatics. https://doi.org/10.3233/shti250074
Vancouver
Bilionis I, Fernandez Luque L, Ponce Aix S, Bosch-Barrera J, Arnaiz P, Flores A. Data-Driven Assessment of Lung Cancer Patients Using Performance Status and Wearable Device Metrics. Studies in Health Technology and Informatics. 2025. doi:10.3233/shti250074
BibTeX
@article{Bilionis2025,
author = {Bilionis, Ioannis and Fernandez Luque, Luis and Ponce Aix, Santiago and Bosch-Barrera, Joaquim and Arnaiz, Pablo and Flores, Andrés},
title = {Data-Driven Assessment of Lung Cancer Patients Using Performance Status and Wearable Device Metrics},
journal = {Studies in Health Technology and Informatics},
year = {2025},
doi = {10.3233/shti250074}
}
EUVIMED